 |
BSD Medical Corporation Staff
|
|
Hyperthermia therapy is a treatment used in battling cancer by heating tumors. The Heating is about as warm as a hot tub. Research has shown that heat can damage or kill cancer cells in some tumors while also making radiation therapy more effective in treating some tumors that are recurrent or progressive despite conventional therapy.
While it has been known for hundreds of years that fevers can kill cancer, only recently has technology been developed that can control and focus heat specifically on tumors. This technology is found in the BSD-500 Hyperthermia System.
The BSD-500 Hyperthermia System has been approved by the FDA for use alone or in conjunction with radiation therapy in the palliative management of certain solid surface and subsurface malignant tumors (i.e., melanoma, squamous- or basal-cell carcinoma, adenocarcinoma, or sarcoma) that are progressive or recurrent despite conventional therapy.
Clinical studies using BSD's hyperthermia systems in conjunction with radiation therapy have shown that 83.7% of patients had some tumor regression (reduction), 37.4% of patients had a complete tumor regression and 24.5% had a greater than 50% tumor regression.
Although hyperthermia has the potential for producing a variety of adverse effects, those regularly observed during clinical studies have been limited to the direct effects of heating upon tissue and indirect effects related to tumor necrosis (death). See enclosed document for complete information on the FDA approved indications for use and side effects.
Medical facilities offering hyperthermia treatment can be found across the United States, as well as internationally. Always consult with your physician regarding any treatment, including hyperthermia.
Hyperthermia therapy in conjuction with chemotherapy is investigational in the U.S. and can only be given under a clinical study protocol approved by the FDA.
|
